Subsequently, we treated CRC cells with both IBA and a c‐Myc inhibitor (10074‐G5) simultaneously and found that 10074‐G5 reversed the upregulation effect of IBA on PD‐L1, both at the protein level (Figure 3C) and mRNA level (Figure 3D). The gene discussed is MYC; the disease is colorectal carcinoma.